The cellular therapy landscape continues to evolve beyond hematologic malignancies, now making significant progress in solid ...

A tougher crackdown on student cell phones in schools is being considered by Hoosier lawmakers, just one year after they ...

A bill that would ban cellphone use from "bell to bell" was advanced out of committee Tuesday to a full vote before the state Senate.

ASH 2025 oral presentation on SENTI-202 in 20 Relapsed/Refractory Acute Myeloid Leukemia (R/R AML) patients (18 response evaluable) shows high efficacy: 50% ORR and 42% CR/CRh (100% of CRs and 83% of ...

The engagement establishes a multi-phase framework to support AI enabled capital efficient development of Teverelix, a next generation GnRH antagonist, as a first in class market product for acute ...

Detectives allege that Martin incited the family's rottweiler to attack Jamaria, who was found with cuts, bruises, and other ...

OnePlus could launch its new Turbo series next month, with leaks pointing to a massive 9,000mAh battery and a clear focus on ...

Q4 2025 showcased the industry’s pivot toward precise biology, localised delivery, and earlier intervention – with multiple ...

Insider.comNews Commentary – The FDA is moving to require just one clinical trial for new drug approvals, signaling a dramatic shift toward faster regulatory pathways that could accelerate oncology ...

Patriots quarterback Drake Maye is the next in line to follow the "George Brett Syndrome," where older brothers pushed him to ...

We are delighted that isupartob sodium has been recognized as a first-in-class therapy through the award of its International Nonproprietary Name (INN), which includes a new and distinctive suffix.